Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 5811  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Ľ   Next article
 Ľ   Previous article
 Ľ   Table of Contents

 Resource Links
 Ľ   Similar in PUBMED
 Ľ  Search Pubmed for
 Ľ  Search in Google Scholar for
 ĽRelated articles
 Ľ   Citation Manager
 Ľ   Access Statistics
 Ľ   Reader Comments
 Ľ   Email Alert *
 Ľ   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2521    
    Printed41    
    Emailed1    
    PDF Downloaded121    
    Comments [Add]    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2016  |  Volume : 64  |  Issue : 3  |  Page : 478--484

Giant vestibular schwannomas: Surgical nuances influencing outcome in 179 patients


Department of Neurological Sciences, Christian Medical College, Vellore, Tamil Nadu, India

Correspondence Address:
Prof. Vedantam Rajshekhar
Department of Neurological Sciences, Christian Medical College, Vellore - 632 004, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.181558

Rights and Permissions

Introduction: Giant vestibular schwannomas (VSs; ≥4 cm in size) are considered a separate entity owing to their surgical difficulty and increased morbidity. We studied the clinical presentation and surgical outcomes in a large series of giant VS patients. We also present the surgical nuances, which we believe can improve surgical outcomes. Materials and Methods: The clinical profiles, radiology, surgical results, and complications of 179 consecutive patients with a unilateral giant VS were reviewed. The study population was classified into two groups: Group A (4–4.9 cm, 124 [69.3%] patients) and Group B (≥5 cm, 55 [30.7%] patients). Results: The mean tumor size in Group A was 4.3 ± 0.2 cm (range, 4–4.8 cm), and in Group B, it was 5.3 ± 0.4 (range, 5–6.7 cm). Patients in Group B were younger, with a mean age at presentation of 34.8 ± 12.3 years versus 41.8 ± 13.1 years in Group A (P < 0.05). There was no difference in the clinical presentation except for papilledema (81.8% vs. 66.9%) and VI cranial nerve (CN) dysfunction (9.1% vs. 2.4%; P< 0.05), which was higher in Group B. There was no difference in the rate of total excision (86.2% vs. 85.4%), anatomical and physiological facial nerve preservation rates between the two groups (approximately 2/3 and 1/3, respectively), and the facial function at discharge. The incidence of postoperative morbidity was not statistically different between the two groups, except for the occurrence of postoperative cerebrospinal fluid (CSF) rhinorrhea, which was greater in Group B (10.9% vs. 2.4%). There were two mortalities in each group (overall, 4/179; 2.2%; P= 0.58). Conclusions: Patients with ≥5cm VSs were younger, with a higher incidence of papilledema and lateral rectus paresis. However, when compared with tumors ≥4 cm in size, there was no difference in the extent of excision, facial nerve preservation, and postoperative complications (except CSF rhinorrhea) or mortality. Thus, further subclassification of giant VSs does not seem to be necessary.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow